التفاصيل البيبلوغرافية
العنوان: |
PD-L1 Expression in Pituitary Neuroendocrine Tumors/Pituitary Adenomas |
المؤلفون: |
Giulia Cossu, Stefano La Rosa, Jean Philippe Brouland, Nelly Pitteloud, Ethan Harel, Federico Santoni, Maxime Brunner, Roy Thomas Daniel, Mahmoud Messerer |
المصدر: |
Cancers ; Volume 15 ; Issue 18 ; Pages: 4471 |
بيانات النشر: |
Multidisciplinary Digital Publishing Institute |
سنة النشر: |
2023 |
المجموعة: |
MDPI Open Access Publishing |
مصطلحات موضوعية: |
biological behavior, immune checkpoint inhibitors, immunotherapy, PD-L1, PitNET, pituitary adenoma, prognosis, somatotroph pituitary tumors, gonadotroph pituitary tumors |
الوصف: |
Background and aim: About a third of Pituitary Neuroendocrine Tumors (PitNETs) may show aggressive behavior. Many efforts have been performed for identifying possible predictive factors to early determine the future behavior of PitNETs. Programmed cell death ligand 1 (PD-L1) expression was associated with a more aggressive biology in different solid tumors, but its role in PitNET is not well-established yet. Our study aims to analyze PD-L1 expression in a surgical cohort of PitNETs to determine its association with radiological invasion and pathology findings, as well as with long-term recurrence rates. Methods: We performed a retrospective analysis in a series of 86 PitNETs. Clinical presentation and radiological features of the preoperative period were collected, as well as pathological data and follow-up data. The rate of PD-L1 expression was immunohistochemically evaluated and expressed as a tumor proportion score (TPS). We assessed its relationship with cavernous sinus invasion and Trouillas’ classification as primary outcomes. Secondary outcomes included the TPS’ relationship with histopathological markers of proliferation, hormonal expression, tumor size and long-term recurrence rates. We calculated the optimal cut-point for the primary outcomes while maximizing the product of the sensitivity and specificity and then we evaluated the significance of secondary outcomes with logistic regression analysis. Results: Eighty-six patients were included in the analysis; 50 cases were non-functional PitNETs. The TPS for PD-L1 showed a highly right-skewed distribution in our sample, as 30.2% of patients scored 0. Using Trouillas’ classification, we found that “proliferative” cases have a significantly higher probability to express PD-L1 in more than 30% of tumor cells (OR: 5.78; CI 95%: 1.80–18.4). This same cut-point was also associated with p53 expression. A positive association was found between PD-L1 expression and GH expression (p = 0.001; OR: 5.44; CI 95%: 1.98–14.98), while an inverse relationship was found ... |
نوع الوثيقة: |
text |
وصف الملف: |
application/pdf |
اللغة: |
English |
العلاقة: |
Cancer Therapy; https://dx.doi.org/10.3390/cancers15184471Test |
DOI: |
10.3390/cancers15184471 |
الإتاحة: |
https://doi.org/10.3390/cancers15184471Test |
حقوق: |
https://creativecommons.org/licenses/by/4.0Test/ |
رقم الانضمام: |
edsbas.66138B4F |
قاعدة البيانات: |
BASE |